Appian Community and Appian Academy are being upgraded. As a part of the upgrade, Appian Community is currently in read-only mode, and user registration is disabled until August 3. We apologize for any inconvenience this may cause, but a more secure, stable, and performant Community experience is coming soon!
The new Appian Community launches August 3, followed by Appian Academy on August 7. During the migration, Appian Community Edition, Appian Academy, Documentation, Certifications, Instructor-led Customer Training, Partner Sales Training & Accreditation, and Forum (for Appian Partners and Customers only) will remain available.
Overview
Study Start-Up, or SSU, is the phase that prepares clinical trial sites for activation. It involves completing regulatory approvals, collecting essential documents, finalizing site readiness, and coordinating across multiple teams and systems—all while ensuring speed, accuracy, and compliance.
Traditionally, Study Start-Up is highly manual and fragmented. The following are some challenges encountered with these traditional methods:
Key Features & Functionality
The Study Start-Up solution uses Process Automation and Agentic AI to bring structure, intelligence, and transparency into the entire SSU lifecycle. It automates the generation of complex SSU documents, adapts to country-specific regulations through configurable business rules, and proactively manages milestones and risks using AI Agents—delivering faster, more compliant, and scalable Study Start-Up across global clinical trials.
By combining Process Automation and Agentic AI, SSU brings structure, intelligence, and transparency into the entire Study Start-Up lifecycle. Here are some of the highlights of the solution.